43 results
SC14D9C
EX-99.1
KNTE
Kinnate Biopharma Inc
21 Feb 24
Written communication relating to third party tender offer
6:01am
to attract, hire and retain highly skilled executive officers and employees; our ability to protect our intellectual property; reliance on third
8-K
EX-99.1
KNTE
Kinnate Biopharma Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:10am
to attract, hire and retain highly skilled executive officers and employees; our ability to protect our intellectual property; reliance on third
8-K
EX-99.1
KNTE
Kinnate Biopharma Inc
9 Nov 23
Kinnate Biopharma Inc. Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
4:14pm
States and other countries; our ability to attract, hire and retain highly skilled executive officers and employees; our ability to protect our
8-K
EX-99.1
KNTE
Kinnate Biopharma Inc
18 Sep 23
Kinnate Biopharma Inc. Announces Pipeline Updates, Strategic Reprioritization and Workforce Restructuring
4:28pm
, hire and retain highly skilled executive officers and employees; difficulties in managing our growth; our ability to protect our intellectual property
8-K
EX-99.1
et1r ufh6ew
8 Aug 23
Kinnate Biopharma Inc. Reports Second Quarter 2023 Financial Results and Recent Corporate Updates
4:16pm
8-K
EX-99.1
v154rdx45n
11 May 23
Kinnate Biopharma Inc. Reports First Quarter 2023 Financial Results and Recent Corporate Updates
4:15pm
8-K
EX-99.2
ve0k gy03j6h5q
17 Apr 23
Results of Operations and Financial Condition
3:15pm
8-K
EX-99.1
3ju1c6w
17 Apr 23
Results of Operations and Financial Condition
3:15pm
8-K
EX-99.1
s5lvt7r 1gxqjz826f
10 Nov 22
Kinnate Biopharma Inc. Announces Third Quarter 2022 Financial Results and Recent Corporate Updates
4:26pm
8-K
EX-99.1
yasfe40qcscz
11 Oct 22
Kinnate Biopharma Inc. Announces Recent Corporate Updates, Including on the Ongoing KIN-2787 Monotherapy Dose Escalation from Global Phase 1 Trial
4:17pm
8-K
EX-99.1
z3exx l9g3pa695
11 Aug 22
Kinnate Biopharma Inc. Announces Second Quarter 2022 Financial Results and Recent Corporate Updates
4:15pm
8-K
EX-99.1
oo0tlwsqwxqnhz2 kj
12 May 22
Kinnate Biopharma Inc. Reports First Quarter 2022 Financial Results and Provides Operational Updates
4:16pm